Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of aortic stenosis, offering a minimally invasive alternative to open-heart surgery. Now an Indian company seems to have promising progress with their product. Among the emerging technologies in this space is the Myval TAVR valve, developed by Meril Life Sciences, headquartered...